New Enterprise Associates 12, Limited Partnership - Net Worth and Insider Trading

New Enterprise Associates 12, Limited Partnership Net Worth

The estimated net worth of New Enterprise Associates 12, Limited Partnership is at least $1.0 Billion dollars as of 2025-06-07. New Enterprise Associates 12, Limited Partnership is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $783 Million. New Enterprise Associates 12, Limited Partnership is the 10% Owner of Echo Global Logistics Inc and owns about 2,420,219 shares of Echo Global Logistics Inc (ECHO) stock worth over $117 Million. New Enterprise Associates 12, Limited Partnership is also the 10% Owner of Liquidia Corp and owns about 2,484,870 shares of Liquidia Corp (LQDA) stock worth over $45 Million. Besides these, New Enterprise Associates 12, Limited Partnership also holds ChannelAdvisor Corp (ECOM) , Ardelyx Inc (ARDX) , Proteostasis Therapeutics Inc (PTI) , Zosano Pharma Corp (ZSANQ) . Details can be seen in New Enterprise Associates 12, Limited Partnership's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that New Enterprise Associates 12, Limited Partnership has not made any transactions after 2019-11-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of New Enterprise Associates 12, Limited Partnership

New Enterprise Associates 12, Limited Partnership Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, New Enterprise Associates 12, Limited Partnership owns 17 companies in total, including Ardelyx Inc (ARDX) , Proteostasis Therapeutics Inc (PTI) , and Liquidia Corp (LQDA) among others .

Click here to see the complete history of New Enterprise Associates 12, Limited Partnership’s form 4 insider trades.

Insider Ownership Summary of New Enterprise Associates 12, Limited Partnership

Ticker	Company	Transaction Date	Type of Owner
ARDX	Ardelyx Inc	2016-07-18	10 percent owner
PTI	Proteostasis Therapeutics Inc	2019-11-27	10 percent owner
LQDA	Liquidia Corp	2018-07-30	10 percent owner
		2018-02-26	10 percent owner
		2017-02-13	10 percent owner
		2016-06-14	10 percent owner
		2016-02-03	10 percent owner
		2014-01-30	10 percent owner
		2014-08-27	10 percent owner
		2013-11-12	10 percent owner
		2011-11-03	10 percent owner
		2012-10-11	10 percent owner
		2009-10-01	10 percent owner
		2011-03-10	10 percent owner
		2009-04-03	10 percent owner
		2016-02-10	10 percent owner
		2016-02-10	10 percent owner

New Enterprise Associates 12, Limited Partnership Latest Holdings Summary

New Enterprise Associates 12, Limited Partnership currently owns a total of 7 stocks. Among these stocks, New Enterprise Associates 12, Limited Partnership owns 24,538,379 shares of iShares Indl/Office Real Estate Capped (FNIO) as of November 28, 2011, with a value of $783 Million and a weighting of 77.08%. New Enterprise Associates 12, Limited Partnership owns 2,420,219 shares of Echo Global Logistics Inc (ECHO) as of October 1, 2009, with a value of $117 Million and a weighting of 11.5%. New Enterprise Associates 12, Limited Partnership also owns 2,484,870 shares of Liquidia Corp (LQDA) as of July 30, 2018, with a value of $45 Million and a weighting of 4.44%. The other 4 stocks ChannelAdvisor Corp (ECOM) , Ardelyx Inc (ARDX) , Proteostasis Therapeutics Inc (PTI) , Zosano Pharma Corp (ZSANQ) have a combined weighting of 6.97% among all his current holdings.

Latest Holdings of New Enterprise Associates 12, Limited Partnership

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FNIO	iShares Indl/Office Real Estate Capped	2011-11-28	24,538,379	31.89	782,528,906
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
LQDA	Liquidia Corp	2018-07-30	2,484,870	18.14	45,075,542
ECOM	ChannelAdvisor Corp	2013-11-12	1,661,357	23.09	38,360,733
ARDX	Ardelyx Inc	2016-07-18	8,752,543	3.68	32,209,358
PTI	Proteostasis Therapeutics Inc	2019-11-27	213,535	1.11	237,024
ZSANQ	Zosano Pharma Corp	2017-02-13	1,361	0.00	0

Holding Weightings of New Enterprise Associates 12, Limited Partnership

New Enterprise Associates 12, Limited Partnership Form 4 Trading Tracker

According to the SEC Form 4 filings, New Enterprise Associates 12, Limited Partnership has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 1,291,493 shares on November 28, 2011, which brought New Enterprise Associates 12, Limited Partnership around $41 Million.

According to the SEC Form 4 filings, New Enterprise Associates 12, Limited Partnership has made a total of 0 transactions in Echo Global Logistics Inc (ECHO) over the past 5 years. The most-recent trade in Echo Global Logistics Inc is the sale of 0 shares on October 1, 2009, which brought New Enterprise Associates 12, Limited Partnership around $0.

According to the SEC Form 4 filings, New Enterprise Associates 12, Limited Partnership has made a total of 0 transactions in Liquidia Corp (LQDA) over the past 5 years. The most-recent trade in Liquidia Corp is the acquisition of 545,455 shares on July 30, 2018, which cost New Enterprise Associates 12, Limited Partnership around $6 Million.

More details on New Enterprise Associates 12, Limited Partnership's insider transactions can be found in the Insider Trading History of New Enterprise Associates 12, Limited Partnership table.

Insider Trading History of New Enterprise Associates 12, Limited Partnership

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

New Enterprise Associates 12, Limited Partnership Trading Performance

GuruFocus tracks the stock performance after each of New Enterprise Associates 12, Limited Partnership's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by New Enterprise Associates 12, Limited Partnership is 39.62%. GuruFocus also compares New Enterprise Associates 12, Limited Partnership's trading performance to market benchmark return within the same time period. The performance of stocks bought by New Enterprise Associates 12, Limited Partnership within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how New Enterprise Associates 12, Limited Partnership's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of New Enterprise Associates 12, Limited Partnership

Average Return

Average return per transaction

Outperforming Transactions

2 out of 6 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	18.21
Relative Return to S&P 500(%)	16.41

New Enterprise Associates 12, Limited Partnership Ownership Network

Ownership Network List of New Enterprise Associates 12, Limited Partnership

No Data

Ownership Network Relation of New Enterprise Associates 12, Limited Partnership

New Enterprise Associates 12, Limited Partnership Owned Company Details

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include Chief Medical Officer Laura A Williams , Chief Financial Officer Justin A Renz , and director & President & CEO Michael Raab .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, New Enterprise Associates 12, Limited Partnership made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 653,019 shares made by Michael Raab , a net sale of 279,567 shares made by David P. Rosenbaum , and a net sale of 500,947 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 166,809 shares of Ardelyx Inc (ARDX) in total and bought 481,377 shares, with a net purchase of 314,568 shares. During the past 18 months, 2,218,499 shares of Ardelyx Inc (ARDX) were sold and 1,187,274 shares were bought by its insiders, resulting in a net sale of 1,031,225 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include Chief Medical Officer Rajeev Saggar , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, New Enterprise Associates 12, Limited Partnership made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 24,399 shares made by Jason Adair , a net sale of 56,175 shares made by Rajeev Saggar , and a net sale of 31,937 shares made by Scott Moomaw .

In summary, during the past 3 months, insiders sold 114,769 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 114,769 shares. During the past 18 months, 505,793 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,517,598 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does Tintri Inc do?

Who are the key executives at Tintri Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Tintri Inc. Other key executives at Tintri Inc include director & Chairman & CEO Kenneth Klein , 10 percent owner Insight Venture Associates Viii, Ltd. , and 10 percent owner Insight Venture Associates Viii, L.p. .

Tintri Inc (TNTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tintri Inc (TNTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tintri Inc (TNTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tintri Inc (TNTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tintri Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Scott D Sandell , and 10 percent owner M James Barrett .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Patrick J Kerins , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, New Enterprise Associates 12, Limited Partnership made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 15,000 shares were bought by its insiders, resulting in a net purchase of 10,417 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , Co-President Sayan Chakraborty , and EVP & General Counsel & Secty Richard Harry Sauer .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, New Enterprise Associates 12, Limited Partnership made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 3,068,327 shares made by David A Duffield , a net sale of 39,841 shares made by Sayan Chakraborty , and a net sale of 35,000 shares made by Still George J Jr .

In summary, during the past 3 months, insiders sold 397,923 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 397,923 shares. During the past 18 months, 3,209,271 shares of Workday Inc (WDAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,209,271 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, New Enterprise Associates 12, Limited Partnership made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 3,405 shares made by Daniel R. Chevallard ,

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,405 shares of Viracta Therapeutics Inc (VIRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,405 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

New Enterprise Associates 12, Limited Partnership is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

New Enterprise Associates 12, Limited Partnership Mailing Address

Above is the net worth, insider trading, and ownership report for New Enterprise Associates 12, Limited Partnership. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, New Enterprise Associates 12, Limited Partnership's mailing address is: Baltimore Md 21202.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.